A new method to visualize molecules involved in oxidative stress in cells and tissues.
An Activity-Based Biomolecule Labeling Platform for the Imaging of Cells and Tissues Under Oxidative Stress
This study is working on a new way to see harmful molecules in living cells that can cause diseases like cancer and neurodegeneration, using special dyes that can help us understand how these molecules affect our health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10916547 on NIH RePORTER |
What this research studies
This research focuses on developing a novel platform for imaging reactive oxygen species (ROS) in living cells and tissues. By creating specialized fluorescent probes that can permanently record the presence of ROS, the study aims to improve our understanding of how these molecules contribute to various diseases, including neurodegeneration and cancer. The approach involves synthesizing unique fluorophores that can trap ROS, allowing for more accurate imaging and analysis of cellular signaling processes. This could lead to better insights into the role of oxidative stress in health and disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by conditions associated with oxidative stress, such as Alzheimer's disease or certain cancers.
Not a fit: Patients with conditions unrelated to oxidative stress or those not currently experiencing neurodegenerative or cancerous processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of oxidative stress-related diseases and potentially lead to new diagnostic or therapeutic strategies.
How similar studies have performed: Other research has shown promise in using fluorescent probes for imaging cellular processes, indicating that this approach has potential for success.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Messina, Marco — University of Delaware
- Study coordinator: Messina, Marco
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.